Genespire

Curated by Signal

Developer of transformative gene therapies for people affected by genetic diseases

Overview

Developer of transformative gene therapies for people affected by genetic diseases. The company's lead product includes GENE 101 for X-linked HIGM syndrome. Other candidates include GENE 102, 201, and 202 for inherited metabolic diseases.

Key facts

Founded: 2019
Headquarters: Milano, Italy
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

FATRO
Veterinary pharmaceutical company providing drug research and production for animal health
Life Sciences TechnologyOzzano dell'Emilia, Italy
Amolab
Portable pregnancy diagnostics & monitoring devices
Life Sciences TechnologyLecce, Italy
Roadrunnerfoot Engineering
Prosthetic foot and knee devices
Life Sciences TechnologyMilan, Italy

About Genespire

What does Genespire do?

Developer of transformative gene therapies for people affected by genetic diseases.

Where is Genespire headquartered?

Genespire is headquartered in Milano, Italy.

When was Genespire founded?

Genespire was founded in 2019.

Which sector is Genespire in?

Genespire operates in Life Sciences Technology.

Who are Genespire's competitors?

Companies similar to Genespire include FATRO, Amolab, and Roadrunnerfoot Engineering.